Alcon claims control of cell therapy firm Aurion Eyecare giant Alcon has bought a majority stake in cell therapy start-up Aurion Biotech, replacing the company's chief executive.

NEWS: Eyecare giant #Alcon has bought a majority stake in #celltherapy start-up #AurionBiotech, replacing the company's chief executive, in the culmination of a months-long struggle for control.

pharmaphorum.com/news/alcon-c...